back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-05-28 14:15 Tx date 2024-05-27 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-141,396.75
-394 vol $358.88 each |
75,100 | |
| Filed 2023-12-26 10:55 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,050
+65,000 vol $0.37 each |
75,494 | |
| Filed 2023-12-06 08:18 Tx date 2023-12-05 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-311,322
-848 vol $367.13 each |
10,494 | |
| Filed 2022-12-19 13:45 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$13,350
+7,500 vol $1.78 each |
11,342 | |
| Filed 2022-11-17 15:17 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,850
+7,500 vol $2.78 each |
||
| Filed 2022-11-15 18:02 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,850
+7,500 vol $2.78 each |
||
| Filed 2022-11-15 18:02 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,850
+7,500 vol $2.78 each |
11,342 | |
| Filed 2022-10-12 18:00 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-509 vol |
21 | |
| Filed 2022-10-12 17:58 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-92,218 vol |
3,842 | |
| Filed 2022-02-24 12:03 Tx date 2022-02-23 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,050
+5,000 vol $1.01 each |
96,060 | |
| Filed 2021-10-20 12:14 Tx date 2021-10-18 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
91,060 | |
| Filed 2020-12-17 17:06 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
61,060 | |
| Filed 2020-12-17 16:59 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-993,940 vol |
31,060 | |
| Filed 2020-12-17 16:14 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-16,970 vol |
530 | |
| Filed 2019-07-04 15:10 Tx date 2019-07-04 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,440
+17,500 vol $0.368 each |
17,500 | |
| Filed 2019-07-04 15:08 Tx date 2018-11-05 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-05-31 12:54 Tx date 2019-05-27 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+325,000 vol |
1,025,000 | |
| Filed 2018-12-10 Tx date 2018-11-05 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-10 Tx date 2018-12-05 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$311,500
+700,000 vol $0.445 each |
700,000 |